Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ARRJF OTCMKTS:CAKFY OTCMKTS:SHTDY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARRJFArjo AB (publ)$2.97$2.97$3.27▼$3.51N/AN/A1,450 shsN/ACAKFYMcKesson Europe$4.10$4.10$4.04▼$4.10N/AN/A10,050 shsN/ASHTDYSinopharm Group$10.71-1.2%$11.98$10.57▼$14.87N/AN/A68,170 shs70,984 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARRJFArjo AB (publ)0.00%0.00%0.00%0.00%-3.42%CAKFYMcKesson Europe0.00%0.00%0.00%0.00%0.00%SHTDYSinopharm Group+1.31%+0.28%-7.43%-18.68%-11.37%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARRJFArjo AB (publ)$2.97$2.97$3.27▼$3.51N/AN/A1,450 shsN/ACAKFYMcKesson Europe$4.10$4.10$4.04▼$4.10N/AN/A10,050 shsN/ASHTDYSinopharm Group$10.71-1.2%$11.98$10.57▼$14.87N/AN/A68,170 shs70,984 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARRJFArjo AB (publ)0.00%0.00%0.00%0.00%-3.42%CAKFYMcKesson Europe0.00%0.00%0.00%0.00%0.00%SHTDYSinopharm Group+1.31%+0.28%-7.43%-18.68%-11.37%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARRJFArjo AB (publ) 0.00N/AN/AN/ACAKFYMcKesson Europe 0.00N/AN/AN/ASHTDYSinopharm Group 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARRJFArjo AB (publ)N/AN/AN/AN/AN/AN/ACAKFYMcKesson EuropeN/AN/AN/AN/AN/AN/ASHTDYSinopharm GroupN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARRJFArjo AB (publ)N/AN/AN/AN/AN/AN/AN/AN/A7/14/2026 (Estimated)CAKFYMcKesson EuropeN/A$0.0947.67N/AN/AN/AN/AN/AN/ASHTDYSinopharm GroupN/A$4.992.15N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthARRJFArjo AB (publ)N/AN/AN/AN/AN/ACAKFYMcKesson Europe$0.040.91%N/A43.18%N/ASHTDYSinopharm GroupN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARRJFArjo AB (publ)N/ACAKFYMcKesson Europe0.01%SHTDYSinopharm GroupN/AInsider OwnershipCompanyInsider OwnershipARRJFArjo AB (publ)N/ACAKFYMcKesson EuropeN/ASHTDYSinopharm GroupN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARRJFArjo AB (publ)6,500N/AN/ANot OptionableCAKFYMcKesson Europe26,329N/AN/ANot OptionableSHTDYSinopharm Group115,959N/AN/ANot OptionableSHTDY, ARRJF, and CAKFY HeadlinesRecent News About These CompaniesSinopharm Group Announces Executive Director ChangesNovember 6, 2025 | msn.comSinopharm Group Schedules Board Meeting to Review Interim ResultsAugust 13, 2025 | msn.comSinopharm Group Co. Ltd. ADR (SHTDY) Stock Price Today - WSJJuly 17, 2025 | wsj.comSinopharm Group Updates Final Dividend Distribution for 2024June 12, 2025 | tipranks.comSinopharm Group Co. Ltd. Reports Successful AGM and Shareholder MeetingsJune 12, 2025 | tipranks.comStudy: Sinopharm COVID-19 vaccines appear safe, effectiveMay 12, 2025 | asahi.comASinopharm Group Reports Q1 2025 Financial ResultsApril 27, 2025 | tipranks.comSinopharm Accord Reports Q1 2025 Financial Results with Declines in Revenue and ProfitApril 24, 2025 | tipranks.comSinopharm Group’s 2024 Transformation and Innovation DriveMarch 23, 2025 | tipranks.comSinopharm’s CNMDC Reports Decline in 2024 Financial PerformanceMarch 20, 2025 | tipranks.comSinopharm Reports Mixed Financial Results for 2024March 19, 2025 | tipranks.comSome 47 Chinese workers in Uganda inoculated with the Sinopharm vaccine allegedly tested positiveJanuary 30, 2025 | en.mercopress.comE3 Compelling Dividend Stocks Offering Yields Up To 5.1%January 28, 2025 | finance.yahoo.comSinopharm Group Schedules EGM for Board Director AppointmentsJanuary 19, 2025 | tipranks.comSinopharm Accord Projects Notable Profit Decline for 2024January 19, 2025 | tipranks.comSinopharm Group Proposes New Director AppointmentsJanuary 8, 2025 | tipranks.comAnalysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Sinopharm Group Co (OtherSHTDF)December 12, 2024 | markets.businessinsider.com3 Dividend Stocks Yielding Up To 4.5%November 8, 2024 | finance.yahoo.comCobenfy Approved for Adult Patients with SchizophreniaSeptember 28, 2024 | empr.comERevolutionary drug for schizophrenia wins US approvalSeptember 28, 2024 | nature.comNSHTDY, ARRJF, and CAKFY Company DescriptionsArjo AB (publ) OTCMKTS:ARRJF$2.97 0.00 (0.00%) As of 06/10/2026Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.McKesson Europe OTCMKTS:CAKFY$4.10 0.00 (0.00%) As of 07/11/2023McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products. This division serves its customers through 90 wholesale branches that supply pharmaceutical products to approximately 40,000 pharmacies and hospitals, as well as operates 70 distribution centers in Europe. The Retail Pharmacy division operates approximately 2,000 owned pharmacies and approximately 8,000 members in its brand partnership program. This division also provides outpatient drug, e-commerce, and home care services primarily in Belgium, Ireland, Italy, and the United Kingdom under the Lloyds Pharmacy brand. In addition, this division provides traditional prescription drugs, over-the-counter products, and medical services. It also provides other services for pharmacists, such as the organization and management of pharmacy cooperation programs in the Great Britain, France, Portugal, and Belgium. The company was formerly known as Celesio AG and changed its name to McKesson Europe AG in September 2017. The company was founded in 1835 and is headquartered in Stuttgart, Germany. McKesson Europe AG is a subsidiary of McKesson Corporation.Sinopharm Group OTCMKTS:SHTDY$10.71 -0.13 (-1.20%) As of 02:59 PM EasternSinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Spotify's "North Star" Outlook Was Music to Investors Ears DraftKings Hits the Jackpot With Super App Pivot Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress SpaceX IPO Fears Are Overblown, But the AI Bet Is Real The Biggest Opportunity From SpaceX’s IPO May Surprise You NVIDIA’s Outlook Gains Momentum: Stock Price to Follow Chewy’s Growth Engine Is Stronger Than the Market Thinks Casey’s Is Looking Like a Hot Buy as Growth, Buybacks, and Guidance Align Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
